Article Versions Notes

Ghanim B, Baier D, Pirker C, Müllauer L, Sinn K, Lang G, Hoetzenecker K, Berger W. Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib. Cancers. 2022; 14(22):5602. https://doi.org/10.3390/cancers14225602

Ghanim, Bahil, Dina Baier, Christine Pirker, Leonhard Müllauer, Katharina Sinn, Gyoergy Lang, Konrad Hoetzenecker, and Walter Berger. 2022. "Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib" Cancers 14, no. 22: 5602. https://doi.org/10.3390/cancers14225602

Ghanim, B., Baier, D., Pirker, C., Müllauer, L., Sinn, K., Lang, G., Hoetzenecker, K., & Berger, W. (2022). Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib. Cancers, 14(22), 5602. https://doi.org/10.3390/cancers14225602